Siga Delivers First Courses of Smallpox Antiviral Drug Arestvyr to U.S.

Siga Technologies has delivered first courses of smallpox antiviral drug arestvyr under a Biomedical Advanced Research and Development Authority contract to the U.S. government's Strategic National Stockpile.
Pharmaceutical Business Review